Hologic Inc. (HOLX)
Hologic's International Momentum Takes Shape: Will Execution Pay Off?
HOLX is leaning into international growth with Surgical division strength and untapped demand driving momentum abroad.
Hologic (HOLX) Laps the Stock Market: Here's Why
In the closing of the recent trading day, Hologic (HOLX) stood at $65.37, denoting a +2.64% move from the preceding trading day.
Hologic Q3 Preview: Tariff Pressure And Undervalued Stock Price, Initiate With Buy
I am initiating a Buy rating on Hologic, Inc. with a fair value of $81, as current risks are priced in. Hologic's strong diagnostic portfolio, recurring consumables revenue, and expanding assay menu support long-term growth in women's health. Short-term margin pressure from tariffs is expected, but normalization and margin expansion should resume from FY26 onward.
Is Hologic Stock a Risky Investment Ahead of Its Q3 Earnings Report?
HOLX heads into Q3 earnings with revenue and EPS estimates down, tariff pressures mounting, and stock lagging peers.
Hologic Rides on AI-Powered Breast Health Innovations: What's Next?
HOLX advances breast health with AI tools like Genius Detection PRO and the upcoming Envision 3D platform.
Why Hologic (HOLX) Dipped More Than Broader Market Today
The latest trading day saw Hologic (HOLX) settling at $63.26, representing a -2.1% change from its previous close.
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
Hologic's GYN Surgical Dominance: What's Powering the Road Ahead?
HOLX's GYN Surgical arm gains momentum with Fluent Pro, global expansion and strategic acquisitions fueling growth.
Hologic (HOLX) Surpasses Market Returns: Some Facts Worth Knowing
In the latest trading session, Hologic (HOLX) closed at $65.85, marking a +1.46% move from the previous day.
Is Hologic Stock's Low Valuation an Opportunity or a Value Trap?
HOLX trades below peers on P/S, but falling EPS, weak Breast Health sales and China risks cloud the outlook.
Hologic Faces Molecular Drag, But Here's Why It's Not a Major Concern
HOLX's Molecular Diagnostics growth stays resilient, as new assays and test adoption offset funding headwinds.
Hologic (HOLX) Surpasses Market Returns: Some Facts Worth Knowing
In the most recent trading session, Hologic (HOLX) closed at $65.11, indicating a +1.31% shift from the previous trading day.
